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Summary
Objective: To identify the characteristics of cells isolated from pannus-like soft tissue on osteoarthritic cartilage (OA pannus cells), and to
evaluate the role of this tissue in osteoarthritis (OA).
Methods: OA pannus cells were isolated from pannus-like tissues in five joints obtained during arthroplasty. The phenotypic features of the
isolated cells were characterized by safranin-O staining and immunohistochemical studies. Expression of MMP-1, MMP-3 and MMP-13 was
also assessed using reverse transcriptase-polymerase chain reactions (RT-PCR), enzyme-linked immunosorbent assay (ELISA) and
immunocytochemistry.
Results: Foci and plaque formation of pannus-like tissue over cartilage surface were found in 15 of 21 (71.4%) OA joints macroscopically,
and among them, only five samples had enough tissue to be isolated. OA pannus cells were positive for type I collagen and vimentin, besides
they also expressed type II collagen and aggrecan mRNA. Spontaneous expression of MMP-1, MMP-3 and MMP-13 was detected in OA
pannus cells. Similar or higher levels of MMPs were detected in the supernatant of cultured OA pannus cells compared to OA chondrocytes,
and among these MMP-3 levels were relatively higher in OA pannus cells. Immunohistochemically, MMP-3 positive cells located
preferentially in pannus-like tissue on the border of original hyaline cartilage.
Conclusion: Our results showed that OA pannus cells shared the property of mesenchymal cells and chondrocytes; however, their origin
seemed different from chondrocytes or synoviocytes. The spontaneous expression of MMPs suggests that they are involved in the articular
degradation in OA.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Osteoarthritis (OA) is the most common form of arthropathy,
and the major cause of disability in the elder. Histological
studies of osteoarthritic joints show that the prominent
change is the loss of hyaline cartilage from part or whole of
the articular surface, accompanied by new bone formation
(osteophyte). In addition, foci and plaques of new non-
osseous tissue were often seen at the surface of diseased
joints, which was considered as a phenomenon of remod-
eling process1. The histological appearance of the new
tissue is described as a pannus-like fibrous tissue,
chodroid, fibrocartilage or a form of hyaline cartilage1–3.
Pannus is now known as invasive granulation tissue
observed on articular surface of rheumatoid arthritis (RA)
joints; however, the word ‘pannus’ originated in appearance
like cloth that covered articular surface. Contrary to RA
pannus, which had been extensively studied4, little atten-
tion has been paid to the non-cartilaginous tissue covering
OA cartilage. Recently, Shibakawa et al. reported that 80%
of articular samples from OA patients had pannus-like
tissue that had catabolic properties5.
Matrix metalloproteinases (MMPs) play an important role
in degeneration of articular cartilage in OA6,7. Recent
studies have shown that MMP-1, MMP-3 and MMP-13
were present in synovial fluid (SF) from OA patients8–10,
and the severity of cartilage damage corresponded with
synovial MMP activity11. By detecting degraded products of
type II collagen and proteoglycan, the presence of specific
MMP activity was elucidated in vivo12–14. In OA, the
production of these MMPs was upregulated in synovial
tissue15,16, in SF cells17, in chondrocytes18–20 and in
pannus-like tissue on OA cartilage5.
In this study, we isolated cells from the pannus-like
tissue on advanced OA cartilage (OA pannus cells) and
cultivated them to investigate their phenotype and function.
The production and expression of collagen, aggrecan and
MMPs (MMP-1, MMP-3, and MMP-13) by these cells were
evaluated and compared to that of chondrocytes from the
same cartilage samples.
Patients and methods
CARTILAGE SAMPLES
Articular cartilage specimens were obtained from 21
patients who met the criteria of American College of
Rheumatology for OA21 and underwent arthroplasty.
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All the samples were from medial type knee OA or hip OA
in advanced stage. Macroscopically, 15 of the 21 (71.4%)
specimens had pannus-like tissue varying in size and
locations, and we used 5 of the 15 specimens, which had
enough tissue to be isolated (four knee joints and one
hip joint, four females and one male, mean age of 76 years
ranging from 56 to 94 years). All the samples were
obtained with informed consent from the patients, and the
study protocol was approved by the institutional ethical
committee.
CELL PREPARATION
Pannus-like tissue was grazed off bluntly and gently from
the residual hyaline cartilage as a thick material (Fig. 1). As
pannus-like tissue occupied less than 30% of the surface of
residual cartilage in OA with little quantity, it was difficult to
detach enough samples discriminating two tissue types,
fibrous type and vascular type, both of which were pre-
viously found5. Attention was paid not to scrape residual
cartilage to cause contamination. OA pannus cells were
prepared as follows. Pannus-like tissue was minced and
then digested by rotating overnight at 37°C in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco BRL, NY) con-
taining 1 mg/ml of bacterial collagenase (Sigma, MO). A
part of the removed tissue was analyzed histologically to
confirm that no piece of hyaline cartilage was included. The
cells released by enzymatic digestion were filtered through
a sterile nylon strainer (Becton Dickinson, NJ), washed,
and centrifuged. The pellet was seeded into a 90 mm
diameter dish (Sumitomo Medical Co., Tokyo) at a density
of 2–4×105–4×105 cells/dish and cultivated at 37°C in a
humidified atmosphere of 5% CO2. The culture medium
used was DMEM containing 10% heat-inactivated fetal calf
serum (FCS; Gibco BRL) and 1% penicillin/streptomycin
(Gibco BRL). Medium was replaced every week, and cells
were used within the second passages. Chondrocytes
were isolated from the residual hyaline cartilage taken from
the articular region that was not covered with soft tissue.
Fibroblast-like synoviocytes from synovium of the same
samples were used as controls.
SAFRANIN-O STAINING AND IMMUNOSTAINING
Cells were seeded in eight-well chamber slides (Nunc,
Naperville, IL) at a concentration of 2×104 cells per well and
were cultured for 3–5 days. The slides were fixed using 4%
formaldehyde in phosphate buffered saline (PBS) con-
taining 0.1% saponin at room temperature for 30 min.
Safranin-O staining was performed according to the
method described previously22. Immunostaining was per-
formed using HistoMark kits (streptavidin–horseradish per-
oxidase; KPL, Gaithersburg, MD). After fixation, slides were
preincubated with heat-inactivated 10% goat serum at
room temperature for 30 min, and then incubated at room
temperature for 1 h with mouse anti-human collagen type I,
collagen type II (Chemocon Int. Inc., Temecula, CA, 20 µg/
ml), vimentin (Sigma, MO, 1:200) or anti-human MMP-3
(Fuji-Chemical Co., Japan, 10 µg/ml) monoclonal anti-
bodies. Slides were washed twice with 0.04 M Tris buffered
saline (pH 7.6) containing 0.1% saponin, then sequentially
incubated twice with a biotinylated goat anti-mouse
immunoglobulin and streptavidin–peroxidase conjugate at
room temperature for 30 min. The streptavidin–peroxidase
was then visualized using diaminobenzidine. Slides were
counterstained with hematoxylin and evaluated with a
bright-field microscope. For histochemical or immunohisto-
chemical study, 5 µm thick sections of paraffin-embedded
specimens were prepared and subjected to staining as
mentioned above.
DETECTION OF MMP-1, MMP-3, AND MMP-13 OF ENZYME-LINKED
IMMUNOSORBENT ASSAY (ELISA)
The levels of MMP-1, MMP-3 and MMP-13 in super-
natants were evaluated with commercially available ELISA
kits according to the instructions of the manufacturer
(Amersham Pharmacia Biotech, UK). These assays were
Fig. 1. Collection of pannus-like tissue from articular surface of
lateral tibial condyle of the knee sample. The tissue was removed
bluntly and gently from residual cartilage using a scalpel.
Table I
Primer sequences used for reverse transcription-polymerase chain
reaction
Primer sequences (5′–3′) Fragment
size (bp)
Type II procollagen
Sense: 5′-AACTGGCAAGCAAGGAGACA-3′ 621
Antisense: 5′-AGTTTCAGGTCTCTGCAGGT-3′
Aggrecan
Sense: 5′-ATGCCCAAGACTACCAGTGG-3′ 501/318
Antisense: 5′-TCCTGGAAGCTCTTCTCAGT-3′
Type I procollagen
Sense: 5′-TGACGAGACCAAGAACTG-3′ 599
Antisense: 5′-CCATCCAAACCACTGAAACC-3′
MMP-1
Sense: 5′-CTGAAGGTGATGAAGCAGCC-3′ 428
Antisense: 5′-AGTCCAAGAGAATGGCCGAG-3′
MMP-3
Sense: 5′-CCTCTGATGGCCCAGAATTGA-3′ 440
Antisense: 5′-GAAATTGGCCACTCCCTGGGT-3′
MMP-13
Sense: 5′-CTATGGTCCAGGAGATGAAG-3′ 390
Antisense: 5′-AGAGTCTTGCCTGTATCCTC-3′
GAPDH
Sense: 5′-CCACCCATGGCAAATTCCATGGCA-3′ 598
Antisense: 5′-TCTAGACGGCAGGTCAGGTCCA
CC-3′
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Fig. 2. Macroscopic (A, C and E) and microscopic (B, D and F; hematoxylin and eosin staining) views of articular surface of morbid joints.
(A) and (B) show osteoarthritic knee joint without soft tissue from a 56-year-old male patient. Defect of cartilage is demarcated by distinct
border of residual cartilage and lacerated surface is exposed directly. (C) and (D) show osteoarthritic knee joint with pannus-like tissue
(arrowhead) from a 68-year-old female patient. Articular cartilage was partly covered with soft tissue like a cloth or a carpet. Histological
finding is fibrous (fibrous type according to previous study5). (E) and (F) show rheumatoid arthritic knee joint from a 44-year-old patient with
RA pannus. Articular surface was covered with invasive soft tissue with local bleeding. Histological findings show hypervascularity and
infiltration of inflammatory cells.
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capable of measuring each free proMMP as well as active
MMP–TIMP-1 complex.
REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
(RT-PCR) ANALYSIS
Total RNA was extracted from 1×106 isolated cells
using the single-step guanidinium thiocyanate–phenol–
chloroform method (RNAzol B solution; Tel-Test, TX). RNA
was precipitated in ethanol, recovered by centrifugation,
resuspended in 10 µl of sterile water, and evaluated
spectrophotometrically for quantity and purity. First-strand
complementary DNA (cDNA) was synthesized in a 20-µl
reaction mixture containing 5 µg of total RNA, 2.5 mM of
each dNTP, 1 mM of random hexamer primers, 40 units of
ribonuclease inhibitor (RNasin; Toyobo, Tokyo, Japan), and
200 units of Superscript II RT (Gibco BRL), by incubation at
42°C for 2 h. The resulting cDNA (2 µl) was subjected to
PCR using Taq DNA polymerase (TaKaRa, Japan) and the
specific primers for Col I, Col II, aggrecan, and MMPs. PCR
for Col I, Col II and aggrecan was performed for 35 cycles
at 94°C for 30 s, 56°C for 30 s, and 72°C for 30 s, and
MMPs were amplified in a protocol of 94°C for 1 min, 60°C
for 1 min, and 72°C for 1 min for 22 cycles to yield amplifi-
cation in the linear range, in a PCR thermal cycler
(TaKaRa)23. In each experiment, amplification of cDNA for
the housekeeping gene GAPDH was used as an internal
standard. The primer sequences are listed in Table I 24–26.
PCR products were electrophoresed on 1.5% agarose
gels, stained with ethidium bromide (10 mg/ml), and bands
were visualized and photographed under ultraviolet illumi-
nation. The intensity of signal was quantified by an image
analyzer, FLA 2000 (Fuji Film, Japan).
STATISTICAL ANALYSIS
For statistical analysis, Wilcoxon signed-ranks test was
used to compare paired values and Mann–Whitney test for
non-paired samples.
Results
MACROSCOPIC AND MICROSCOPIC FINDINGS OF ARTICULAR
SURFACE IN OA AND RA
Macroscopically, the pannus-like tissue spread as a foci
or plaque over residual hyaline cartilage in some OA
samples [Fig. 2(C)]. Though there were samples lacking
soft tissue covering [Fig. 2(A and B)], pannus-like tissue
was found at the margins of articular surface or in more
central areas [Fig. 2(C)], unlike RA pannus that spreads
diffusely and invasively all over the articular surface with
local bleeding [Fig. 2(E)]. Whereas RA pannus showed
hypervascularity with infiltrating inflammatory cells ac-
companied by lymph follicles [Fig. 2(F)], pannus-like tissue
of OA had less vascularity and fibrous property [Fig. 2(D)].
As is shown in the previous report5, pannus-like tissue in
OA was divided into two tissue types, fibrous type and
vascular type, and was negative for proteoglycan pre-
sented by safranin-O staining. Contrary to cells infiltrating
RA pannus, cells in OA pannus tissue were negative for
CD68 (data not shown). The thickness of pannus over OA
cartilage varied from only a thin layer to up to 5 mm.
EXPRESSION OF TYPE I COLLAGEN, TYPE II COLLAGEN, VIMENTIN
AND PROTEOGLYCAN IN OA PANNUS CELLS
The previous study showed that pannus-like tissue of OA
expressed type I collagen but not type II collagen or
proteoglycan5. In the present study, the expression of
chondrocyte specific molecules, type II collagen and aggre-
can, as well as type I collagen and vimentin was
investigated in OA pannus cells by RT-PCR and immuno-
cytochemistry.
RT-PCR showed that not only type II collagen and
aggrecan, but also type I collagen was expressed in OA
pannus cells in five samples obtained, though the intensity
of type II collagen was relatively weak; on the other hand,
chondrocytes expressed type II collagen and aggrecan,
and synovial samples expressed only type I collagen in all
samples tested. Figure 3 shows a representative result
from five different samples.
In immunocytochemistry, OA pannus cells were faintly
stained by safranin-O in two of the five samples; on the
other hand, chondrocytes were strongly stained in all the
samples. Moreover, OA pannus cells were positive for type
I collagen, type II collagen and also vimentin (Fig. 4).
Synoviocytes were only positive for type I collagen and
chondrocytes were positive for safranin-O and type II
collagen. Vimentin is a marker for cells of mesenchymal
origin and positive for mesenchymal adherent cells in RA
SF27, whereas its expression was quite low in OA synovio-
cytes28. In this study, only OA pannus cells were positive
for vimentin suggesting that they are of mesenchymal
origin.
EXPRESSION AND PRODUCTION OF MMP-1, MMP-3 AND MMP-13 BY
OA PANNUS CELLS
MMP-3 and IL-1 were positive in pannus-like tissue
of OA, this tissue was speculated to have catabolic rather
than anabolic property5. Thus we further investigated the
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Fig. 3. RT-PCR image of type I collagen (Col I), type II collagen
(Col II) and aggrecan expression in articular components of OA.
Fibroblast-like synoviocytes (A), OA pannus cells (B) and chondro-
cytes (C). These cells were derived from the same patient.
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expression and production of MMPs (MMP-1, -3 and -13)
by isolated cells from the tissue.
RT-PCR analysis revealed that MMP-1, MMP-3 and
MMP-13 were expressed in all OA pannus cell samples
with various intensities [Fig. 5(A)]. In contrast, four of the
five samples and only one sample expressed MMP-1 and
MMP-3, respectively, in OA chondrocytes. All OA pannus
cell samples expressed MMP-13. Although no significant
difference was found in relative intensity, there was a
tendency for MMP-3 to be higher and MMP-13 to be lower
in OA pannus cells [Fig. 5(B)].
The expression of MMP-1, MMP-3 and MMP-13 in OA
pannus cells was also confirmed by immunocytochemical
study. OA pannus cells were revealed to express these
MMPs and the expression of MMP-3 and -13 was stronger
[Fig. 6(A–D)]. As MMP-3 was revealed to be the major
MMP produced from isolated chondrocytes stimulated with
IL-1 or TNF29, in vivo localization was confirmed in three
samples by immunohistochemistry. A representative picture
showed that a considerable number of cells in pannus-like
tissue were positive for MMP-3, while fewer chondrocytes
were positive in hyaline cartilage underlying the tissue
[Fig. 6(E)].
The production of MMP-1, MMP-3 and MMP-13 from OA
pannus cells and chondrocytes in culture supernatant was
also analyzed by ELISA. As shown in Fig. 7, the production
of MMP-3 was significantly higher in OA pannus cells;
however, no significant difference was shown in other
MMPs. The levels of MMP-1 and MMP-13 were relatively
low compared with those of MMP-3.
Discussion
Shibakawa et al. showed that pannus-like tissue was
found on OA cartilage, preferentially located in the mar-
ginal region of the joint and could be classified into the
vascular type and the fibrous type. From the detailed
histological observation, they speculated that the tissue
was reparative in the earlier stage of OA, but changed to
be catabolic after the long-term exposure to factors such
as cytokines or growth factors involved in OA5. Pannus-
like tissue in OA was different from RA pannus in the
following ways: (1) it often occurred as foci or plaque
over cartilage surface, unlike RA pannus which distrib-
uted diffusely over the cartilage; (2) its cell density was
less than that of RA pannus, especially on the border of
original hyaline cartilage; and (3) in contrast to RA
pannus, neither lymphocyte follicles nor CD68+ cells
were found.
In regard to the incidence of pannus-like tissue, Meachim
and Osborne examined 20 osteoarthritic femoral heads
and reported that soft tissue, varying in pattern from fibrous
to loose-textured, was found in all the specimens and
occupied 10–55% of the diseased joint surface1,2. In our
study, articular surface was observed macroscopically and
pannus-like tissue was found in 71.4% of joint samples.
The incidence may vary according to the stage of the
disease and the joint examined. Anyway, the exact inci-
dence of pannus occurring in early stage OA needs to
be further investigated in arthroscopic study or using an
animal model.
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Fig. 4. Representative picture of safranin-O staining and immunostaining for type II collagen (Col II), type I collagen (Col I) and vimentin in
articular components of OA. Fibroblast-like synoviocytes (Syno), OA pannus cells (OA pannus) and chondrocytes (Chon). Bar=50 µm.
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As the property of pannus-like tissue was different from
that of hyaline cartilage, we further investigated the cells
isolated from this tissue. We found that OA pannus cells
strongly expressed a fibroblastic marker, type I collagen;
however, they also expressed type II collagen and aggre-
can mRNA to some extent. Thus, OA pannus cells shared
some properties of chondrocytes. OA pannus cells might
include heterogeneous cells, unlike chondrocytes, con-
sidering the fact that pannus-like tissue of OA was classi-
fied into fibrous type and vascular type; however, in situ
properties of both were similar5.
As for the origin of pannus-like tissue of OA, it can
spread over the joint surface from synovial tissue at the
articular margins or it may be caused by fibrous metaplasia
of cartilage as it shared the common property of chondro-
cytes. Another candidate is soft tissue of subarticular origin
that gains access to the surface through gaps in the
bone1,2. The fact that only OA pannus cells expressed
vimentin, a mesenchymal marker, supports the possibility
that its origin is subarticular mesenchymal cells.
As mentioned above, pannus-like tissue of OA had a
catabolic property, although it is speculated to be reparative
in the earlier stage of this disease. A previous report also
described cartilage erosion by this tissue30. In this regard, it
might have, partly, some common properties as RA pannus
in cartilage destruction. In this study, we confirmed the
expression of MMP-1 -3 and -13, and showed that OA
pannus cells as well as OA chondrocytes expressed
MMPs; especially, OA pannus cells produced more
MMP-3 than OA chondrocytes at protein level. Distinctive
expression of MMP-3 was found only in one sample by
RT-PCR, which was inconsistent with the result from
ELISA, as MMP-3 was detected in the culture supernatant
of all samples as shown in Fig. 7. One of the reasons
for this inconsistency might be insufficient amplification
(22 cycles) to get the semi-quantitative results. MMP-3
expression was detected in OA chondrocytes amplified for
35 cycles (data not shown).
Since it is well known that these MMPs play a crucial role
in cartilage damage by degrading cartilage components
including collagen types II, IX, XI and proteoglycan31,32, our
results support the previous speculation that pannus-like
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Fig. 5. (A) RT-PCR analysis for MMP-1, MMP-3 and MMP-13
expression in OA pannus cells (lanes 1–5) and chondrocytes
(lanes 6–10) from OA patients. M, molecular weight marker; N,
negative control (no template); P, positive control (TNF-stimulated
chondrocytes). (B) Intensity of the signals analyzed by an image
analyzer. Values were intensity relative to that of GAPDH. Though
no significant difference was found, there was a tendency for
MMP-3 to be higher and MMP-13 to be lower in OA pannus cells.
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Fig. 6. Immunostaining of MMPs in OA pannus cells (A–D) and MMP-3 in OA cartilage (E). (A) MMP-1, (B) MMP-3, (C) MMP-13; (D) control.
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tissue of OA is involved in further cartilage degradation,
especially in advanced OA. This leads to the hypothesis
that cartilage defects may be bridged by fibrous tissue for
repair, but continual joint movement or unfavorable circum-
stances such as exposure to cytokines may make it unlikely
for a repair process to succeed. The expression of proteo-
glycan and type II collagen suggests the possibility of repair
by this tissue in some condition, even though catabolic
factors are also expressed.
In conclusion, we demonstrated pannus-like tissue over
OA cartilage, and the cells isolated from this tissue shared
properties of mesenchymal cells and chondrocytes to some
extent. In addition, OA pannus may be involved in cartilage
degradation in OA by producing MMPs. Our results shed
light on the role of soft tissue in cartilage degradation in OA,
suggesting the possibility of new therapeutic strategy in
OA, by targeting pannus-like tissue of OA to prevent
cartilage from further degradation.
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